NASDAQ:EIDX Investor Notice: Investigation Concerning Possible Wrongdoing at Eidos Therapeutics, Inc.

San Diego, CA -- (SBWIRE) -- 05/29/2019 -- Certain directors of Eidos Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.